Ligand Pharmaceuticals Inc $49.14

down -2.31


22/7/2014 04:00 PM  |  NASDAQ : LGND  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get LGND Trend Analysis - it has underperformed the S&P 500 by 18%

Partner Headlines

  1. Fed Says Districts Were Optimistic On Economic Outlook; Yahoo! Falls On ...

    Benzinga
  2. Yahoo Falls On Downbeat Results; Time Warner Shares Spike Higher

    Benzinga
  3. Benzinga's Volume Movers

    Benzinga
  4. Ligand to Present Positive Data from Phase 1 Study of Effect of SERN Lasofoxifene ...

    Benzinga
  5. Shares Of Ligand Follow Parabolic Curve Amid Responses Surrounding Promacta's ...

    Benzinga
  6. Ligand Pharmaceuticals - Severe competitive threat to key royalty program ...

    GuruFocus
  7. Indexes End With Small Gains; Tesla Drives Higher

    IBD
  8. UPDATE: Ligand Signs Research and Licensing Agreement with Omthera Pharmaceuticals ...

    Benzinga
  9. UPDATE: Ligand Pharma Announces Milestone from Sage Therapeutics for SAGE-547

    Benzinga
  10. Spectrum Pharmaceuticals' Pivotal Trial of Captisol-Enabled (Propylene ...

    Benzinga
  11. UPDATE: MLV & Co Reiterates on Ligand Pharmaceuticals Following Strong ...

    Benzinga
  12. Stocks End Near Session Highs; Ligand, Regeneron Jump

    IBD
  13. Ligand Pharmaceuticals Poised For Full-Year Profit

    IBD
  14. UPDATE: Cantor Fitzgerald Raises PT on Ligand Pharmaceuticals as Key Partnered ...

    Benzinga
  15. Ligand Pharmaceuticals Sees Q4 EPS $0.31-$0.32 vs $0.22-$0.24; Q4 Revenue ...

    Benzinga
  16. A Few Stocks Form Bases, But Have Flaws

    IBD
  17. Ligand Pharmaceuticals On Pace For Annual Profit

    IBD
  18. Ligand, NIC: Thinly Traded Stocks That Hold Promise

    IBD
  19. Ligand Partner GSK Receives Marketing Authorization from EC for Additional ...

    Benzinga
  20. Ligand Enters Global License Agreement with CURx Pharmaceuticals for Captisol-Enabled ...

    Benzinga
  21. Ligand Receives FDA Orphan Designation for Captisol-Enabled Topiramate ...

    Benzinga
  22. UPDATE: Cantor Fitzgerald Downgrades Ligand Pharmaceuticals to Hold, Lowers ...

    Benzinga
  23. FDA Accepts NDA for Pfizer, Ligand's Bazedoxifene/Conjugated Estrogens

    Benzinga
  24. Ligand Pharma Begins Pivotal Trial of Captisol-Enabled Propylene Glycol-Free ...

    Benzinga
  25. Ligand Pharmaceuticals, Inc. (LGND) CEO John L Higgins buys 2,000 Shares

    GuruFocus
  26. Benzinga's Volume Movers

    Benzinga
  27. Ligand Pharma, Glaxo Confirm PROMACTA Receives FDA Ok for New Indication

    Benzinga
  28. Ligand Pharmaceuticals Inc. Reports Operating Results (10-K/A)

    GuruFocus
  29. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  30. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  31. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  32. Ligand Pharma Announces Preclinical Data for LG-7501

    Benzinga
  33. Ligand to Receive $2 Million Milestone Payment from Merck; Re-Affirms FY ...

    Benzinga
  34. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  35. Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental ...

    Benzinga
  36. One Drugmaker Soars, 1 Falls

    IBD
  37. Onyx Up, Celgene Down On Cancer Drug News

    IBD
  38. ConAgra Foods, HONDA MOTOR CO. Among Stocks Up on High Volume Thursday

    FoxBusiness
  39. Ligand Pharmaceuticals Inc. Reports Operating Results (10-K)

    GuruFocus
  40. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  41. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  42. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  43. MLV & Co Affirms Ligand Pharmaceuticals Buy, $30 PT

    Benzinga
Trading Center